Your browser doesn't support javascript.
loading
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study.
L'Orphelin, J-M; Cassecuel, J; Kandolf, L; Harwood, C A; Tookey, P; Junejo, M H; Hogan, S; Lebbé, C; Appalla, Z; Kränke, T-M; Pellacani, G; Cerasuolo, D; Dujovic, B; Del Marmol, V; Forschner, A; Garbe, C; Bataille, V; Ressler, J M; Sollena, P; Dompmartin, A; Peris, K; Dreno, B.
  • L'Orphelin JM; Department of Dermatology, Caen-Normandie University Hospital, Caen, France.
  • Cassecuel J; Nantes Université, Nantes - Angers INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes, France.
  • Kandolf L; Department of Dermatology, Medical Faculty Military Medical Academy, Belgrade, Serbia.
  • Harwood CA; Department of Dermatology, Second Floor, South Tower, Royal London Hospital, Barts Health NHS Trust Whitechapel, E1 1 BB and Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.
  • Tookey P; Department of Dermatology, Second Floor, South Tower, Royal London Hospital, Barts Health NHS Trust Whitechapel, E1 1 BB and Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.
  • Junejo MH; Department of Dermatology, Second Floor, South Tower, Royal London Hospital, Barts Health NHS Trust Whitechapel, E1 1 BB and Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.
  • Hogan S; Department of Dermatology, Second Floor, South Tower, Royal London Hospital, Barts Health NHS Trust Whitechapel, E1 1 BB and Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.
  • Lebbé C; Department of Dermatology, APHP Hôpital Saint Louis, Paris, France.
  • Appalla Z; Second Department of Dermatology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Kränke TM; Department of Dermatology, Medical University of Graz, Graz, Austria.
  • Pellacani G; Department of Dermatology, University of Modena and Reggio Emilia via del Pozzo 71, Modena, Italy.
  • Cerasuolo D; Biostatistics and Clinical Research Unit, Caen-Normandy University Hospital, Caen, France.
  • Dujovic B; Department of Dermatology, Medical Faculty Military Medical Academy, Belgrade, Serbia.
  • Del Marmol V; Department of Dermatology - Hôpital Erasme, Université Libre de Bruxelles, Bruxelles, Belgium.
  • Forschner A; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Garbe C; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Bataille V; Department of Dermatology, Hemel Hempstead Hospital NHS, London, UK.
  • Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna, Austria.
  • Sollena P; Department of Medical Science, Dermatology, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
  • Dompmartin A; Department of Dermatology, Caen-Normandie University Hospital, Caen, France.
  • Peris K; Department of Medical Science, Dermatology, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
  • Dreno B; Department of Dermatology, Catholic University of Rome, Rome, Italy.
J Eur Acad Dermatol Venereol ; 2023 Apr 12.
Article en En | MEDLINE | ID: mdl-37042810
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2023 Tipo del documento: Article